Swiss look into effects of delayed Pfizer vaccine deliveries
A health worker prepares the Pfizer-BioNTech COVID-19 vaccination at Lausanne University Hospital earlier this week
Keystone / Laurent Gillieron
Pfizer-BioNTech has temporarily slowed shipments of its coronavirus vaccine to Europe. The Swiss health authorities say they are looking into the consequences for Switzerland.
This content was published on
3 minutes
Keystone-SDA/SRF/Reuters/AP/swissinfo.ch/ilj
Several European Union countries have saidExternal link that they are receiving fewer doses for the Pfizer-BioNTech vaccine. In a statement on FridayExternal link, Pfizer confirmed shipments were being affected by changes to its manufacturing processes designed to boost production.
As a result, there would be “a temporary reduction in the number of doses delivered in the upcoming week. We will be back to the original schedule of deliveries to the European Union beginning the week of January 25, with increased delivery beginning week of February 15.”
The company said it would deliver the fully committed quantity of vaccine doses in the first quarter and significantly more in the second quarter.
Swiss reaction
Asked for its reaction to the temporary delay, the Swiss Federal Office of Public Health (FOPH) said on Friday night: “We are taking the new of the supply bottleneck seriously and are looking into the consequences for Switzerland”.
The Swiss government knew from the beginning that the global shortage in vaccine supply would be a challenge, which is why it is following a diversified strategy, the FOPH told several news outlets. “The government is backing several vaccine manufacturers and different vaccine technologies because Covid-19 vaccine development and supply includes many uncertainties,” FOPH spokeswoman Maria Foursova told Swiss public television SRF.External link
National strategy
In total, Switzerland has ordered 15.8 million vaccine shots for its population of 8.6 million: 3 million from Pfizer/BioNTech, 7.5 million from Moderna and 5.3 million from Oxford/AstraZeneca.
Last Tuesday, the health regulator Swissmedic gave the green light for the ‘immediate’ use of the vaccine produced by US company Moderna. It is the second vaccine to be approved in the country after Pfizer/BioNTech’s was cleared for use on December 20. The Pfizer/BioNTech vaccine has already been administered in Switzerland and a further delivery is expected January 18.
It has also been confirmed by government spokesman André Simonazzi that some Swiss government ministers have already received coronavirus vaccinations. But he would not reveal to Keystone-SDA which ministers had received the shot. He said the jab was being administered according to the government’s vaccination strategy and in relation to the job requirements of members of the government.
During an online meeting on Saturday, Swiss Health Minister Alain Berset and the cantons – who are in charge of health matters in Switzerland and are responsible for carrying out the vaccinations – have agreed that the “rhythm” of the vaccinations needed to be faster, news agencies reported.
More
More
Poll: Swiss counting on vaccines to lift them out of the pandemic
This content was published on
The pandemic is beginning to take its toll on the morale of the Swiss but a glimmer of hope has arrived.
Train vs plane: would you take a direct train between London and Geneva?
Eurostar is planning to run direct trains from Britain to Germany and Switzerland from the early 2030s. Would you favour the train over the plane? If not, why not?
This content was published on
The Swiss Broadcasting Corporation (SBC), Swissinfo's parent company, must restructure due to financial pressures and to stay competitive in the fast-moving media environment.
This content was published on
There has been a sharp decline in the consumption of single-use disposable plastic bags and reusable plastic bags in the Swiss retail sector.
This content was published on
A biometric Swiss identity card (ID) is expected to be available in Switzerland by the end of 2026. The Federal Office of Police and its federal and cantonal partners are working on a new ID card that features a chip.
Heatwave reduces output at Swiss nuclear power plant by 50%
This content was published on
The ongoing heatwave has forced the Beznau nuclear power plant, which relies on water from the River Aare, to halve its output.
Swiss continue to enjoy high social mobility, study shows
This content was published on
Opportunities for upward social mobility have remained intact in Switzerland since the 1980s. Social mobility is exceptionally high by international comparison, a study shows.
Swiss government affected by cyberattack on health foundation
This content was published on
Switzerland says a ransomware attack on the non-profit health foundation Radix that involved data being stolen and encrypted had also affected the federal administration.
Federal Council agrees to investigation into alleged Swiss-Russian spying affair
This content was published on
The Office of the Attorney General of Switzerland can open spying investigations into the Swiss Federal Intelligence Service (FIS).
Appeal launched against Starlink satellite antennae project planned in Swiss village
This content was published on
A group of Swiss citizens has filed an appeal against plans to install 40 Starlink satellite antennae in the mountain village of Leuk in southern Switzerland.
UBS launches buyback scheme for up to $2 billion in shares
This content was published on
UBS is starting a share buyback programme for up to $2 billion (CHF1.6 billion) in shares, in line with a plan approved at its annual general meeting (AGM) in April, the Swiss bank said on Monday.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Switzerland has vaccinated over 60,000 for Covid-19
This content was published on
More than 60,000 people have been vaccinated in Switzerland against Covid-19 since late December, according to an official initial estimate.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.